Targeting BH3 Domains in iPSC-Derived Tuberous Sclerosis Kidney Organoids for the Development of Novel Therapies for Renal Angiomyolipoma
DOI:
10.1681/asn.20223311s1609b
Publication Date:
2024-05-17T22:51:00Z
AUTHORS (5)
ABSTRACT
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....